Toews Corp Gilead Sciences, Inc. Transaction History

Toews Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $573,344 - $823,124	-9,200 Reduced 50.27%	9,100 $781,000
Q3 2022 Nov 01, 2022	SELL	$59.54 - $68.01 $125,034 - $142,821	-2,100 Reduced 10.29%	18,300 $1.13 Million
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $784,992 - $884,136	13,600 Added 200.0%	20,400 $1.26 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $393,856 - $493,544	6,800 New	6,800 $404,000
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $382,792 - $434,476	-5,900 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $399,371 - $430,877	5,900 New	5,900 $412,000
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $920,315 - $1.01 Million	-14,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $870,000 - $992,669	14,500 New	14,500 $937,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $872,410 - $994,070	-15,400 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $956,340 - $1.2 Million	15,400 New	15,400 $973,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

Stay updated on Toews Corp with notifications on news.